RATIONALE: Research on the relative impact of trait impulsivity vs. drug exposure on neuropsychological probes of response inhibition vs. response perseveration has been posited as a valid pathway to explore the transition between impulsivity and compulsivity on psychostimulant dependence. OBJECTIVES: The objectives of this study are to examine performance differences between cocaine-dependent individuals (CDI) and healthy comparison individuals (HCI) on neuropsychological probes of inhibition and perseveration and to examine the predictive impact of trait impulsivity-a proxy of premorbid vulnerability, and severity of cocaine use-a proxy of drug exposure, on CDI's performance. METHODS: Forty-two CDI and 65 HCI were assessed using the UPPS-P Scale (trait impulsivity), the Stroop and go/no-go (inhibition) and revised-strategy application and probabilistic reversal tests (perseveration). RESULTS: CDI, compared to HCI, have elevated scores on trait impulsivity and perform significantly poorer on inhibition and perseveration, with specific detrimental effects of duration of cocaine use on perseveration. CONCLUSIONS: CDI have both inhibition and perseveration deficits; both patterns were broadly indicative of orbitofrontal dysfunction in the context of reinforcement learning. Impulsive personality and cocaine exposure jointly contribute to deficits in response perseveration or compulsivity.
RATIONALE: Research on the relative impact of trait impulsivity vs. drug exposure on neuropsychological probes of response inhibition vs. response perseveration has been posited as a valid pathway to explore the transition between impulsivity and compulsivity on psychostimulant dependence. OBJECTIVES: The objectives of this study are to examine performance differences between cocaine-dependent individuals (CDI) and healthy comparison individuals (HCI) on neuropsychological probes of inhibition and perseveration and to examine the predictive impact of trait impulsivity-a proxy of premorbid vulnerability, and severity of cocaine use-a proxy of drug exposure, on CDI's performance. METHODS: Forty-two CDI and 65 HCI were assessed using the UPPS-P Scale (trait impulsivity), the Stroop and go/no-go (inhibition) and revised-strategy application and probabilistic reversal tests (perseveration). RESULTS: CDI, compared to HCI, have elevated scores on trait impulsivity and perform significantly poorer on inhibition and perseveration, with specific detrimental effects of duration of cocaine use on perseveration. CONCLUSIONS: CDI have both inhibition and perseveration deficits; both patterns were broadly indicative of orbitofrontal dysfunction in the context of reinforcement learning. Impulsive personality and cocaine exposure jointly contribute to deficits in response perseveration or compulsivity.
Authors: Chris C Streeter; Devin B Terhune; Theodore H Whitfield; Staci Gruber; Ofra Sarid-Segal; Marisa M Silveri; Golfo Tzilos; Maryam Afshar; Elizabeth D Rouse; Hua Tian; Perry F Renshaw; Domenic A Ciraulo; Deborah A Yurgelun-Todd Journal: Neuropsychopharmacology Date: 2007-06-13 Impact factor: 7.853
Authors: Boris B Quednow; Kai-Uwe Kühn; Christian Hoppe; Jens Westheide; Wolfgang Maier; Irene Daum; Michael Wagner Journal: Psychopharmacology (Berl) Date: 2006-01-20 Impact factor: 4.530
Authors: Jeffrey W Dalley; Tim D Fryer; Laurent Brichard; Emma S J Robinson; David E H Theobald; Kristjan Lääne; Yolanda Peña; Emily R Murphy; Yasmene Shah; Katrin Probst; Irina Abakumova; Franklin I Aigbirhio; Hugh K Richards; Young Hong; Jean-Claude Baron; Barry J Everitt; Trevor W Robbins Journal: Science Date: 2007-03-02 Impact factor: 47.728
Authors: Susan F Tapert; Alecia D Schweinsburg; Sean P A Drummond; Martin P Paulus; Sandra A Brown; Tony T Yang; Lawrence R Frank Journal: Psychopharmacology (Berl) Date: 2007-06-09 Impact factor: 4.530
Authors: Marci R Mitchell; Virginia G Weiss; Dominique J Ouimet; Rita A Fuchs; Drake Morgan; Barry Setlow Journal: Behav Neurosci Date: 2014-05-19 Impact factor: 1.912
Authors: Sébastien Parnaudeau; Kathleen Taylor; Scott S Bolkan; Ryan D Ward; Peter D Balsam; Christoph Kellendonk Journal: Biol Psychiatry Date: 2014-03-26 Impact factor: 13.382